Alzheimer’s Drug Poses a Dilemma for the F.D.A. AAM18:05 NYT > Top Stories Pam Belluck and Rebecca RobbinsIf the agency approves it, aducanumab would be the first new Alzheimer’s treatment sinc...Read More